SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-07-076119
Filing Date
2007-10-22
Accepted
2007-10-22 15:40:59
Documents
7

Document Format Files

Seq Description Document Type Size
1 425 a07-27173_6425.htm 425 32621
2 GRAPHIC g271736bei001.jpg GRAPHIC 5700
3 GRAPHIC g271736bei002.jpg GRAPHIC 5943
4 GRAPHIC g271736bei003.jpg GRAPHIC 2630
5 GRAPHIC g271736bei004.jpg GRAPHIC 1595
6 GRAPHIC g271736bei005.jpg GRAPHIC 16698
7 GRAPHIC g271736bei006.jpg GRAPHIC 1595
  Complete submission text file 0001104659-07-076119.txt   82686
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filed by) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-15006 | Film No.: 071183161
SIC: 2835 In Vitro & In Vivo Diagnostic Substances